La rilevazione dei fattori di rischio per lo sviluppo di infezioni del flusso sanguigno correlate al catetere e trombosi correlata al catetere in pazienti portatori di catetere venoso centrale a inserimento periferico: una scoping review
Abstract
Introduzione: negli ultimi decenni, il catetere venoso centrale ad inserimento periferico (Peripherally Inserted Central Venous Catheter, PICC) è stato riconosciuto come un dispositivo di accesso vascolare efficace e sicuro. Nonostante i grandi vantaggi, i PICC non sono esenti da complicanze. Quelle più note includono le infezioni del flusso sanguigno correlate al catetere (Catheter-Related Bloodstream Infections, CRBSI) e le trombosi venose correlate al catetere (Catheter-Related Venous Thrombosis, CRT). In letteratura c’è ancora poca sintesi sui molteplici fattori connessi a queste complicanze e molta eterogeneità nei tassi di CRBSI e CRT. Questa scoping review mira a identificare le cause che determinano l’insorgenza di complicanze.
Materiali e Metodi: sono state consultate le seguenti banche dati: PubMed, CINAHL, Scopus e Web of Science. La selezione degli studi e l'estrazione dei dati sono state eseguite in modo indipendente da due autori.
Risultati: 19 articoli finali hanno permesso di identificare i fattori correlati all’impianto, al paziente o al management che incidono sull’insorgenza delle complicanze. La tecnica di inserzione, la tipologia del dispositivo vascolare, la patologia e la terapia del paziente sono risultati fattori chiave nello sviluppo dei tassi delle complicanze.
Discussione: la conoscenza della molteplicità dei fattori determinanti le complicanze da PICC è essenziale per migliorare la pratica clinica e gli outcome dei pazienti. Servirebbero ulteriori studi per analizzare quanto l’esperienza degli impiantatori incida sulle complicanze.
Riferimenti bibliografici
- 1. Chopra V, Fallouh N, McGuirk H, et al. Patterns, risk factors and treatment associated with PICC-DVT in hospitalized adults: A nested case-control study. Thromb Res 2015;135:829–34.
- 2. Moran J, Colbert CY, Song J, et al. Screening for novel risk factors related to peripherally inserted central catheter-associated complications. J Hosp Med 2014;9:481–9.
- 3. Wang G, Li Y, Wu C, et al. The clinical features and related factors of PICC-related upper extremity asymptomatic venous thrombosis in cancer patients: A prospective study. Medicine (Baltimore) 2020;99:e19409.
- 4. Webster J, Larsen E, Marsh N, et al. Chlorhexidine gluconate or polyhexamethylene biguanide disc dressing to reduce the incidence of central-line-associated bloodstream infection: a feasibility randomized controlled trial (the CLABSI trial). J Hosp Infect 2017;96:223–8.
- 5. Hao N, Xie X, Zhou Z, Li J, Kang L, Wu H, et al. Nomogram predicted risk of peripherally inserted central catheter related thrombosis. Sci Rep 2017;7:6344.
- 6. Song X, Lu H, Chen F, et al. A longitudinal observational retrospective study on risk factors and predictive model of PICC associated thrombosis in cancer patients. Sci Rep 2020;10:10090.
- 7. Chopra V, Anand S, Hickner A, et al. Risk of venous thromboembolism associated with peripherally inserted central catheters: a systematic review and meta-analysis. Lancet Lond Engl 2013;382:311–25.
- 8. Zhu Y, Li D, Li Y, Cai W. Predictive Model for PICC Occlusion Risk for Patients in Intensive Care Units: A Retrospective Clinical Study. Altern Ther Health Med 2023;29:278–85.
- 9. Chan RJ, Northfield S, Larsen E, et al. Central venous Access device SeCurement And Dressing Effectiveness for peripherally inserted central catheters in adult acute hospital patients (CASCADE): a pilot randomised controlled trial. Trials 2017;18:458.
- 10. Safdar N, Maki DG. Risk of catheter-related bloodstream infection with peripherally inserted central venous catheters used in hospitalized patients. Chest 2005;128:489–95.
- 11. Safdar N, Maki DG. The pathogenesis of catheter-related bloodstream infection with noncuffed short-term central venous catheters. Intensive Care Med 2004;30:62–7.
- 12. Hockenhull JC, Dwan KM, Smith GW, et al. The clinical effectiveness of central venous catheters treated with anti-infective agents in preventing catheter-related bloodstream infections: A systematic review. Crit Care Med 2009;37:702–12.
- 13. Lai NM, Chaiyakunapruk N, Lai NA, et al. Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults. Cochrane Emergency and Critical Care Group, curatore. Cochrane Database Syst Rev 2016;2018:14651858.
- 14. Hughes ME. PICC-related thrombosis: pathophysiology, incidence, morbidity and the effect of ultrasound-guided placement technique on occurrence in cancer patients. J Assoc Vascular Access 2011;16:8–18.
- 15. Rajasekhar A, Streiff MB. How I treat central venous access device–related upper extremity deep vein thrombosis. Blood 2017;129:2727–36.
- 16. Nifong TP, McDevitt TJ. The effect of catheter to vein ratio on blood flow rates in a simulated model of peripherally inserted central venous catheters. Chest 2011;140:48–53.
- 17. Pittiruti M, Brutti A, Celentano D, et al. Clinical experience with power-injectable PICCs in intensive care patients. Crit Care Lond Engl 2012;16:R21.
- 18. Trerotola SO, Stavropoulos SW, Mondschein JI, et al. Triple-lumen peripherally inserted central catheter in patients in the critical care unit: prospective evaluation. Radiology 2010;256:312–20.
- 19. Zochios V, Umar I, Simpson N, Jones N. Peripherally Inserted Central Catheter (PICC)-related thrombosis in critically ill patients. J Vasc Access 2014;15:329–37.
- 20. Sharp R, Carr P, Childs J, et al. Catheter to vein ratio and risk of peripherally inserted central catheter (PICC)-associated thrombosis according to diagnostic group: a retrospective cohort study. BMJ Open 2021;11:e045895.
- 21. Fallouh N, McGuirk HM, Flanders SA, Chopra V. Peripherally inserted central catheter-associated deep vein thrombosis: a narrative review. Am J Med 2015;128:722–38.
- 22. Coyne E, Jose J. An integrative review on non-patient related factors of peripherally inserted central catheter (PICC) infections in hospitalised adult patients. Aust J Cancer Nurs 2017;18:26–36.
- 23. Tricco AC, Lillie E, Zarin W, et al. PRISMA Extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med 2018;169:467–73.
- 24. Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan—a web and mobile app for systematic reviews. Syst Rev 2016;5:210.
- 25. Joanna Briggs Institute. Critical appraisal tools. Available from: https://jbi.global/critical-appraisal-tools
- 26. Moola S, Munn Z, Sears K, et al. Conducting systematic reviews of association (etiology): The Joanna Briggs Institute’s approach. Int J Evid Based Healthc 2015;13:163–9.
- 27. Barker TH, Stone JC, Sears K, et al. The revised JBI critical appraisal tool for the assessment of risk of bias for randomized controlled trials. JBI Evid Synth 2023;21:494–506.
- 28. Aromataris E, Fernandez R, Godfrey CM, et al. Summarizing systematic reviews: methodological development, conduct and reporting of an umbrella review approach. Int J Evid Based Healthc 2015;13:132–40.
- 29. Munn Z, Moola S, Lisy K, et al. Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data. Int J Evid Based Healthc 2015;13:147–53.
- 30. Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021;372:n71.
- 31. Ballard DH, Samra NS, Gifford KM, et al Distance of the internal central venous catheter tip from the right atrium is positively correlated with central venous thrombosis. Emerg Radiol 2016;23:269–73.
- 32. Sheng Y, Yang LH, Wu Y, et al. Implementation of tunneled peripherally inserted central catheters placement in cancer patients: a randomized multicenter study. Clin Nurs Res 2024;33:19–26.
- 33. Li J. A randomized controlled trial to compare peripherally inserted central catheter tunnel lengths in adult patients with cancer. Clin J Oncol Nurs 2023;27:295-304.
- 34. Chopra V, Kaatz S, Grant P, et al. Risk of venous thromboembolism following peripherally inserted central catheter exchange: an analysis of 23,000 hospitalized patients. Am J Med 2018;131:651–60.
- 35. Chopra V, Kaatz S, Conlon A, et al. The Michigan Risk Score to predict peripherally inserted central catheter-associated thrombosis. J Thromb Haemost 2017;15:1951–62.
- 36. Cardoso PC, Rabelo-Silva ER, Martins Bock P, et al. Biomarkers associated with thrombosis in patients with peripherally inserted central catheter: a systematic review and meta-analysis. J Clin Med 2023;12:4480.
- 37. Qiu XX, Guo Y, Fan HB, Shao J, Zhang XB. Incidence, risk factors and clinical outcomes of peripherally inserted central catheter spontaneous dislodgment in oncology patients: a prospective cohort study. Int J Nurs Stud 2014;51:955–63.
- 38. Steele D, Norris CM. Cutting peripherally inserted central catheters may lead to increased rates of catheter-related deep vein thrombosis. J Infus Nurs Off Publ Infus Nurses Soc 2014;37:466–72.
- 39. Balsorano P, Virgili G, Villa G, et al. Peripherally inserted central catheter-related thrombosis rate in modern vascular access era-when insertion technique matters: A systematic review and meta-analysis. J Vasc Access 2020;21:45–54.
- 40. Koo CM, Vissapragada R, Sharp R, et al. ABO blood group related venous thrombosis risk in patients with peripherally inserted central catheters. Br J Radiol 2018;91:20170560.
- 41. Liu K, Zhou Y, Xie W, et al. Handgrip exercise reduces peripherally-inserted central catheter-related venous thrombosis in patients with solid cancers: A randomized controlled trial. Int J Nurs Stud 2018;86:99–106.
- 42. Kim IJ, Shim DJ, Lee JH, et al. Impact of subcutaneous tunnels on peripherally inserted catheter placement: a multicenter retrospective study. Eur Radiol 2019;29:2716–23.
- 43. Herc E, Patel P, Washer LL, et al. A model to predict central-line-associated bloodstream infection among patients with peripherally inserted central catheters: the MPC Score. Infect Control Hosp Epidemiol 2017;38:1155–66.
- 44. Lee JH, Kim ET, Shim DJ, et al. Prevalence and predictors of peripherally inserted central catheter-associated bloodstream infections in adults: A multicenter cohort study. PloS One 2019;14:e0213555.
- 45. Kramer RD, Rogers MAM, Conte M, et al. Are antimicrobial peripherally inserted central catheters associated with reduction in central line-associated bloodstream infection? A systematic review and meta-analysis. Am J Infect Control 2017;45:108–14.
- 46. Kim K, Kim Y, Peck KR. Previous peripherally inserted central catheter (PICC) placement as a risk factor for PICC-associated bloodstream infections. Am J Infect Control 2020;48:1166–70.
- 47. Kurata Y, Ohira G, Hayano K, et al. Peripherally inserted central catheter securement with cyanoacrylate glue and bloodstream infection: A retrospective cohort study. JPEN J Parenter Enteral Nutr 2024;48:215–23.
- 48. Gorski LA, Hadaway L, Hagle ME, et al. Infusion therapy standards of practice, 8th Edition. J Infus Nurs 2021;44:S1–224.
- 49. Dentali F, Sironi A, Ageno W, et al. Non-O blood type is the commonest genetic risk factor for VTE: results from a meta-analysis of the literature. Semin Thromb Hemost 2012;38:535–48.
- 50. Kleidon TM, Horowitz J, Rickard CM, et al. Peripherally inserted central catheter thrombosis after placement via electrocardiography vs traditional methods. Am J Med 2021;134:e79–88.
- 51. Dawson RB. PICC Zone Insertion MethodTM (ZIMTM): a systematic approach to determine the ideal insertion site for piccs in the upper arm. J Assoc Vascular Access 2011;16:156-60.
- 52. Rupp ME, Karnatak R. Intravascular catheter–related bloodstream infections. Infect Dis Clin North Am 2018;32:765–87.
Metriche
Citazioni e attenzione online da Dimensions, Altmetric e PlumX.
Licenza
Copyright (c) 2025 Gli Autori

Questo volume è pubblicato con la licenza Creative Commons Attribuzione - Non commerciale 4.0 Internazionale.
Aniarti ha scelto di applicare la Licenza Creative Commons Attribuzione Non Commerciale 4.0 Internazionale (CC BY-NC 4.0) a tutti i manoscritti da pubblicare.